[ad_1]
Pfeizer says that the experimental pill that the pharmaceutical company has developed against COVID-19, is also effective against the new variant, Omicron.
For this, he cites the full results of the study which seem to be really promising against coronavirus.
2,250 people participated in the experiment which showed that the pill reduced hospitalization and deaths by 89 percent among people at risk in the adult population.
They took the pill shortly after they showed the first symptoms of the disease.
Early laboratory tests have shown that the pill retains its potency against the Omicron variant, said Pfizer, who tested the antiviral drug using key proteins that Omicron uses to reproduce.
In the United States, the Food and Drug Administration is expected to make a decision on whether or not to authorize the use of a Pfizer or Merck pill.
If one of these two pills gets the FDA green light, then Americans infected with the coronavirus will be able to buy it at the pharmacy and be treated at home.
top channel
[ad_2]
Source link
